EFFECT OF SUBCUTANEOUS RECOMBINANT HUMAN ERYTHROPOIETIN ON BLOOD PRESSURE IN PRE-DIALYSIS CHRONIC KIDNEY DISEASE (CKD) PATIENTS

EFFECT OF SUBCUTANEOUS RECOMBINANT HUMAN ERYTHROPOIETIN ON BLOOD PRESSURE IN PRE-DIALYSIS CHRONIC KIDNEY DISEASE (CKD) PATIENTS

Objective: To determine the effect of subcutaneous recombinant human erythropoietin on blood pressure in pre-dialysis chronic kidney disease (CKD) patients. Study Design: Case-series descriptive study. Place and Duration of Study: Combined Military Hospital Peshawar, from Mar 2016 to Sep 2016. Metho...

Full description

Bibliographic Details
Main Authors: Muhammad Sajid Hussain, Qasim Raza, Muhammad Omer Aamir, Nadia Murtaza, Sadia Naureen, Mehwish Razzaq
Format: Article
Language:English
Published: The Army Press 2021-02-01
Series:Pakistan Armed Forces Medical Journal
Subjects:
anemia
chronic kidney disease
erythropoietin
hypertension
Online Access:https://pafmj.org/index.php/PAFMJ/article/view/2489

Internet

https://pafmj.org/index.php/PAFMJ/article/view/2489

Similar Items